BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4129 related articles for article (PubMed ID: 23543555)

  • 1. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia.
    Van Leeuwen E; Petrovic M; van Driel ML; De Sutter AI; Vander Stichele R; Declercq T; Christiaens T
    Cochrane Database Syst Rev; 2018 Apr; 3(3):CD007726. PubMed ID: 29605970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
    Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
    Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special care units for dementia individuals with behavioural problems.
    Lai CK; Yeung JH; Mok V; Chi I
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006470. PubMed ID: 19821370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate preparations for agitation in dementia.
    Baillon SF; Narayana U; Luxenberg JS; Clifton AV
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003945. PubMed ID: 30293233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
    Van Leeuwen E; van Driel ML; Horowitz MA; Kendrick T; Donald M; De Sutter AI; Robertson L; Christiaens T
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013495. PubMed ID: 33886130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Withdrawal versus continuation of antipsychotic drugs in people with dementia].
    Lolk A
    Ugeskr Laeger; 2014 Jul; 176(31):. PubMed ID: 25292325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulated presence therapy for dementia.
    Abraha I; Rimland JM; Lozano-Montoya I; Dell'Aquila G; Vélez-Díaz-Pallarés M; Trotta FM; Cruz-Jentoft AJ; Cherubini A
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011882. PubMed ID: 28418586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Algorithm-based pain management for people with dementia in nursing homes.
    Manietta C; Labonté V; Thiesemann R; Sirsch EG; Möhler R
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD013339. PubMed ID: 35363380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 207.